6 results
Economic aspects of bipolar disorder in Europe
-
- Journal:
- European Psychiatry / Volume 17 / Issue S1 / May 2002
- Published online by Cambridge University Press:
- 16 April 2020, p. 151s
-
- Article
-
- You have access
- Export citation
P02.317 Olanzapine versus risperidone: A prospective comparison of clinical and economic outcomes in schizophrenia
-
- Journal:
- European Psychiatry / Volume 15 / Issue S2 / October 2000
- Published online by Cambridge University Press:
- 16 April 2020, p. 408s
-
- Article
-
- You have access
- Export citation
Frequency and hospitalisation-related costs of manic episodes in patients with bipolar I disorder in France
-
- Journal:
- European Psychiatry / Volume 17 / Issue S1 / May 2002
- Published online by Cambridge University Press:
- 16 April 2020, p. 108s
-
- Article
-
- You have access
- Export citation
Olanzapine or risperidone treatment initiation: SOHO Study Results
-
- Journal:
- European Psychiatry / Volume 17 / Issue S1 / May 2002
- Published online by Cambridge University Press:
- 16 April 2020, p. 150s
-
- Article
-
- You have access
- Export citation
Schizophrenia treatment in Europe: country differences in the SOHO Study
-
- Journal:
- European Psychiatry / Volume 17 / Issue S1 / May 2002
- Published online by Cambridge University Press:
- 16 April 2020, p. 150s
-
- Article
-
- You have access
- Export citation
Baseline results from SOHO: a pan-European, observational study
-
- Journal:
- European Psychiatry / Volume 17 / Issue S1 / May 2002
- Published online by Cambridge University Press:
- 16 April 2020, pp. 150s-151s
-
- Article
-
- You have access
- Export citation